Cervical cancer treatment evolves with molecular screening and immunotherapies, emphasizing early detection as key to improving patient outcomes.
Ruth D. Stephenson, DO, FACOG, FACS
Advertisement
Articles by Ruth D. Stephenson, DO, FACOG, FACS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Sacituzumab Govitecan and Pembrolizumab: A New Frontline for mTNBC
2
FDA Issues Draft Guidance on MRD and CR End Points in Multiple Myeloma
3
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer
4
Pembrolizumab/Cyclophosphamide Combo Yield Efficacy, Safety in Ovarian Cancer
5